drugset / Trial / NCT00910637

Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles

NCT00910637

Phase 3 Completed 1502 enrolled Bayer
Non-randomizedSingle-groupOpen-labelPrevention

Summary

This study is examining a birth control patch for 13 cycles (1 year).

Timeline

Start
2009-05-01
Primary completion
2010-12-13
Completion
2010-12-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Gestodene Small molecule 2.1 mg Other
Subject ethinyl estradiol Small molecule 0.55 mg Other

Indications

No indication recorded.